Clinical Research Market in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Clinical Research Market in Brazil

Clinical Research Market in Brazil – Cohortias the CRO of LATAM

Brazil, a vast and diverse country known for its captivating culture and natural wonders, has also emerged as a key player in the global clinical research market.

With a growing economy, a large and varied patient population, and a progressive regulatory environment, Brazil has become an attractive destination for pharmaceutical and biotech companies seeking to conduct clinical trials.

In this blog, we will explore the factors that contribute to Brazil’s prominence in the clinical research landscape, shedding light on its vast potential and examining the opportunities and challenges it presents.

Size and Diversity of Patient Population:

Brazil’s population of over 200 million people represents a vast and diverse patient pool, encompassing various ethnicities and genetic backgrounds. This diversity offers a unique advantage for conducting clinical trials, as researchers can study drug responses across different subgroups, contributing to more comprehensive and inclusive data analysis.

Leading Pharmaceutical Market in Latin America:

Brazil boasts the largest pharmaceutical market in Latin America, making it an attractive location for clinical research studies. As the demand for novel treatments grows, clinical trials become essential to assess the safety and efficacy of drugs tailored to the specific needs of the Brazilian population.

Developed Healthcare Infrastructure:

Brazil has made significant investments in its healthcare infrastructure, particularly in major cities like São Paulo, Rio de Janeiro, and Brasília. Modern medical facilities, research centers, and well-trained healthcare professionals provide a solid foundation for conducting clinical trials across a wide range of therapeutic areas.

Supportive Regulatory Environment:

The Brazilian Health Regulatory Agency (ANVISA) has taken proactive measures to streamline and expedite the approval process for clinical trials. This supportive regulatory environment, coupled with transparent guidelines, has attracted both domestic and international sponsors looking for efficient trial initiation and execution.

Increasing R&D Investment:

The Brazilian government and private sector have been investing heavily in research and development (R&D) initiatives. These investments not only foster innovation within the country but also encourage foreign companies to collaborate and conduct clinical research studies in Brazil.

Clinical Research Market in Brazil

Clinical Research Market in Brazil

Clinical Research Market in Brazil

Access to Treatment-Naive Patients:

Brazil’s healthcare system has made significant strides in recent years, but access to certain medical treatments may still be limited for some patients. This presents an opportunity for researchers to conduct clinical trials exploring new interventions in treatment-naive populations, contributing to global medical knowledge.

Favorable Cost-Benefit Ratio:

Conducting clinical trials in Brazil often proves cost-effective when compared to more developed countries. The lower costs of labor, medical services, and administrative expenses can significantly optimize research budgets, attracting sponsors looking to maximize their resources.

Challenges:

Despite its immense potential, the clinical research market in Brazil faces certain challenges:

Inequality in Healthcare Access:

Socioeconomic disparities in Brazil can impact healthcare access and the representation of different demographics in clinical trials. Efforts to enhance healthcare equality and increase participation from marginalized communities are crucial for generating comprehensive and equitable research data.

Complex Regulatory Procedures:

While the regulatory environment has improved, navigating Brazil’s administrative processes can still be complex and time-consuming. Continued efforts to simplify and accelerate regulatory approvals will foster a more attractive environment for clinical research.

Language and Cultural Barriers:

Portuguese is the primary language spoken in Brazil, and language barriers can pose challenges for international sponsors and researchers. Effective communication strategies that address linguistic and cultural differences are essential for successful clinical trial execution.

Conclusion:

Brazil’s clinical research market is witnessing exponential growth, bolstered by its diverse patient population, leading pharmaceutical market, and supportive regulatory landscape. With a well-developed healthcare infrastructure and increasing investments in R&D, the country offers lucrative opportunities for pharmaceutical and biotech companies seeking to advance medical research.

Addressing challenges related to healthcare inequality, regulatory procedures, and language barriers will be instrumental in unlocking the country’s full potential in the global clinical research landscape. As Brazil continues to play a pioneering role in clinical research, it will undoubtedly contribute to the development of groundbreaking treatments and improve healthcare outcomes for its own citizens and beyond.

Clinical Research Market in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

The CRO
of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Clinical Research Market in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Clinical Research Market in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Clinical Research Market in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Clinical Research Market in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.

CLINICAL DEVELOPMENT

  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development

CLINICAL TRIAL SERVICES

Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards

MAIN THERAPEUTIC AREAS

  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Clinical Research Market in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Clinical Research Market in Brazil

We provide our services with offices in:

Argentina,
Brazil,
Colombia &
Mexico.

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Clinical Research Market in Brazil

The Cohortias Team

Clinical Research Market in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Clinical Research Market in Brazil

Network & Partnerships